Related Experiment Video
Updated: Mar 2, 2026
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Microbiologic Diagnosis of Respiratory Infections in Critically Ill Immunocompromised Patients
Yupeng Liu1, Chiagozie Pickens2
1Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
Abstract:
Critically ill, immunocompromised individuals are vulnerable to both common and uncommon etiologies of respiratory infection. Identifying the etiology of infection has therapeutic, prognostic, and public health implications. In some circumstances, immunocompromised patients may be empirically treated with excessively broad antibiotics but ultimately be diagnosed with a common cause of pneumonia. In other circumstances, immunocompromised patients may have a non-specific clinical presentation for severe respiratory failure and be diagnosed with a rare etiology of infection. Because this patient population is at risk for a broad array of infections, it is important to understand the advantages and limitations of sampling and diagnostic techniques. Furthermore, the last decades of research have produced novel methods to enhance diagnostic accuracy. Many of these tests are molecular diagnostics that have high sensitivity, but their clinical impact is unknown, particularly in immunocompromised individuals. In this article we discuss various approaches to sampling and microbiologic diagnosis in immunocompromised individuals with severe respiratory failure.
Insights
Diagnosing respiratory infections in immunocompromised patients is crucial. This review covers sampling and diagnostic methods for severe respiratory failure in this vulnerable population.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Critically ill, immunocompromised patients face risks from common and rare respiratory infections.
- Accurate diagnosis impacts treatment, prognosis, and public health measures.
- Non-specific presentations and broad antibiotic use complicate diagnosis in this group.
Purpose of the Study:
- To review sampling and diagnostic techniques for respiratory infections in immunocompromised patients with severe respiratory failure.
- To discuss the advantages and limitations of various diagnostic approaches.
- To highlight novel molecular diagnostic methods and their clinical utility.
Main Methods:
- Review of current literature on respiratory infection diagnostics in immunocompromised patients.
- Discussion of traditional and advanced microbiologic diagnostic techniques.
- Evaluation of molecular diagnostic tools, including their sensitivity and clinical impact.
Main Results:
- Traditional methods have limitations in diagnosing diverse pathogens in immunocompromised hosts.
- Molecular diagnostics offer high sensitivity but their clinical utility requires further investigation.
- Understanding the nuances of sampling and testing is vital for effective management.
Conclusions:
- Optimizing diagnostic strategies is essential for managing respiratory infections in immunocompromised individuals.
- Further research is needed to clarify the clinical impact of novel molecular diagnostics in this population.
- A comprehensive approach to sampling and diagnosis improves patient outcomes and public health.
More Related Videos
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...